IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $198,000 | +88.6% | 20,707 | +277.0% | 0.01% | +75.0% |
| Q4 2021 | $105,000 | +303.8% | 5,492 | +422.5% | 0.00% | +300.0% |
| Q3 2021 | $26,000 | -97.6% | 1,051 | -97.4% | 0.00% | -97.1% |
| Q2 2021 | $1,069,000 | +871.8% | 41,070 | +927.8% | 0.04% | +191.7% |
| Q2 2020 | $110,000 | – | 3,996 | +14700.0% | 0.01% | – |
| Q3 2019 | $0 | -100.0% | 27 | -95.6% | 0.00% | -100.0% |
| Q2 2019 | $15,000 | -21.1% | 617 | -69.4% | 0.00% | -42.9% |
| Q1 2019 | $19,000 | -44.1% | 2,019 | +1.2% | 0.01% | -61.1% |
| Q1 2018 | $34,000 | – | 1,996 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |